Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Return on Equity (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Return on Equity for 4 consecutive years, with 0.11% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 4.0% to 0.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.11% through Dec 2025, down 4.0% year-over-year, with the annual reading at 0.51% for FY2025, 12.0% down from the prior year.
  • Return on Equity hit 0.11% in Q4 2025 for Coya Therapeutics, up from 0.21% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.43% in Q4 2022 to a low of 2.84% in Q1 2023.
  • Historically, Return on Equity has averaged 0.4% across 4 years, with a median of 0.29% in 2024.
  • Biggest five-year swings in Return on Equity: plummeted -177bps in 2023 and later soared 254bps in 2024.
  • Year by year, Return on Equity stood at 1.43% in 2022, then crashed by -124bps to 0.35% in 2023, then soared by 80bps to 0.07% in 2024, then crashed by -53bps to 0.11% in 2025.
  • Business Quant data shows Return on Equity for COYA at 0.11% in Q4 2025, 0.21% in Q3 2025, and 0.26% in Q2 2025.